ENTRY       D10835            Mixture   Drug
NAME        Emtricitabine and tenofovir alafenamide;
            Descovy (TN)
PRODUCT     DESCOVY (Gilead Sciences)
COMPONENT   Emtricitabine [DR:D01199], (Tenofovir alafenamide fumarate [DR:D10605] | Tenofovir alafenamide [DR:D10428])
CLASS       Antiviral
             DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
             DG03107  Anti-HIV agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
            Transporter substrate
             DG01665  ABCB1 substrate
             DG03001  CTSA substrate
REMARK      Therapeutic category: 6250
            ATC code: J05AR17
            Product: D10835<JP/US>
EFFICACY    Antiviral
  DISEASE   HIV infection [DS:H01563]
COMMENT     Tenofovir alafenamide is a substrate of cathepsin A, CYP3A and P-gp.
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
METABOLISM  Enzyme: CTSA [HSA:5476], CYP3A [HSA:1576 1577 1551]
            Transporter: ABCB1 [HSA:5243]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR17 Emtricitabine and tenofovir alafenamide
                  D10835  Emtricitabine and tenofovir alafenamide &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Emtricitabine/ Tenofovir Alafenamide Fumarate
                D10835  Emtricitabine and tenofovir alafenamide
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D10835  Emtricitabine and tenofovir alafenamide
            Drug groups [BR:br08330]
             Antiviral
              DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
               D10835  Emtricitabine and tenofovir alafenamide
              DG03107  Anti-HIV agent
               D10835  Emtricitabine and tenofovir alafenamide
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D10835  Emtricitabine and tenofovir alafenamide
             Transporter substrate
              DG01665  ABCB1 substrate
               D10835  Emtricitabine and tenofovir alafenamide
              DG03001  CTSA substrate
               D10835  Emtricitabine and tenofovir alafenamide
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D10835  Emtricitabine and tenofovir alafenamide
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D10835  Emtricitabine and tenofovir alafenamide &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10835
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10835
             Drug transporters
              D10835
DBLINKS     PubChem: 319902635
///
